Epitomee Medical (Israel) Market Value
| EPIT Stock | 921.50 13.40 1.48% |
| Symbol | Epitomee |
Epitomee Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Epitomee Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Epitomee Medical.
| 12/14/2022 |
| 12/03/2024 |
If you would invest 0.00 in Epitomee Medical on December 14, 2022 and sell it all today you would earn a total of 0.00 from holding Epitomee Medical or generate 0.0% return on investment in Epitomee Medical over 720 days. Epitomee Medical is related to or competes with Clal Biotechnology, Sofwave Medical, Rimon Consulting, Imed Infinity, Bezeq Israeli, Suny Cellular, and ICL Israel. More
Epitomee Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Epitomee Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Epitomee Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.63 | |||
| Information Ratio | 0.1137 | |||
| Maximum Drawdown | 273.98 | |||
| Value At Risk | (7.13) | |||
| Potential Upside | 23.06 |
Epitomee Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Epitomee Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Epitomee Medical's standard deviation. In reality, there are many statistical measures that can use Epitomee Medical historical prices to predict the future Epitomee Medical's volatility.| Risk Adjusted Performance | 0.0996 | |||
| Jensen Alpha | 3.48 | |||
| Total Risk Alpha | (1.02) | |||
| Sortino Ratio | 0.6413 | |||
| Treynor Ratio | 1.73 |
Epitomee Medical Backtested Returns
Epitomee Medical is very steady given 3 months investment horizon. Epitomee Medical secures Sharpe Ratio (or Efficiency) of 0.14, which denotes the company had a 0.14% return per unit of risk over the last 3 months. We were able to analyze twenty-nine different technical indicators, which can help you to evaluate if expected returns of 5.44% are justified by taking the suggested risk. Use Epitomee Medical Coefficient Of Variation of 850.03, downside deviation of 5.63, and Mean Deviation of 10.33 to evaluate company specific risk that cannot be diversified away. Epitomee Medical holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.15, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Epitomee Medical will likely underperform. Use Epitomee Medical downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Epitomee Medical.
Auto-correlation | 0.55 |
Modest predictability
Epitomee Medical has modest predictability. Overlapping area represents the amount of predictability between Epitomee Medical time series from 14th of December 2022 to 9th of December 2023 and 9th of December 2023 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Epitomee Medical price movement. The serial correlation of 0.55 indicates that about 55.0% of current Epitomee Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 72.5 K |
Epitomee Medical lagged returns against current returns
Autocorrelation, which is Epitomee Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Epitomee Medical's stock expected returns. We can calculate the autocorrelation of Epitomee Medical returns to help us make a trade decision. For example, suppose you find that Epitomee Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Epitomee Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Epitomee Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Epitomee Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Epitomee Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Epitomee Medical Lagged Returns
When evaluating Epitomee Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Epitomee Medical stock have on its future price. Epitomee Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Epitomee Medical autocorrelation shows the relationship between Epitomee Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Epitomee Medical.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Epitomee Stock
Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.